Skip to main content
Article
Abstract 1182: Patient derived xenograft (PDX) of human melanoma to predict clinical responses
Cancer Research (2014)
  • Clemens Krepler, Wistar Institute
  • Katrin Sproesser, Wistar Institute
  • Patricia Brafford, Wistar Institute
  • Min Xiao, Wistar Institute
  • Marilda Beqiri, Wistar Institute
  • Wei Xu, University of Pennsylvania
  • Katherine Nathanson, University of Pennsylvania
  • Jennifer Wargo, University of Texas MD Anderson Cancer Center
  • Keith Flaherty, Harvard University
  • Donald L. Morton, 5John Wayne Cancer Institute, Santa Monica, CA;
  • Dave S. Hoon
  • Randall Ryan, 6Helen F. Graham Cancer Center, Newark, DE.
  • Michael Guarino, 6Helen F. Graham Cancer Center, Newark, DE.
  • Nicholas J. Petrelli, 6Helen F. Graham Cancer Center, Newark, DE.
  • David Elder, University of Pennsylvania
  • Xiawei Xu, University of Pennsylvania
  • Giorgos Karakousis, University of Pennsylvania
  • Lynn Schuchter, University of Pennsylvania
  • Meenhard Herlyn, Wistar Institute
Publication Date
October 1, 2014
DOI
10.1158/1538-7445.AM2014-1182
Citation Information
Clemens Krepler, Katrin Sproesser, Patricia Brafford, Min Xiao, et al.. "Abstract 1182: Patient derived xenograft (PDX) of human melanoma to predict clinical responses" Cancer Research Vol. 74 (2014) p. 1182 - 1182
Available at: http://works.bepress.com/dave-hoon/93/